Rankings
▼
Calendar
NTRA Q3 2023 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena
NTRA
Natera, Inc.
$29B
Q3 2023 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$268M
+27.4% YoY
Gross Profit
$121M
45.1% margin
Operating Income
-$111M
-41.4% margin
Net Income
-$109M
-40.6% margin
EPS (Diluted)
$-0.95
QoQ Revenue Growth
+2.6%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$39M
Stock-Based Comp.
$58M
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$662M
Stockholders' Equity
$785M
Cash & Equivalents
$669M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$268M
$211M
+27.4%
Gross Profit
$121M
$94M
+28.5%
Operating Income
-$111M
-$119M
+6.8%
Net Income
-$109M
-$121M
+10.2%
Revenue Segments
Product
$265M
92%
Oncology products
$19M
7%
Licensing and other
$3M
1%
Geographic Segments
United States
$260M
97%
Europe, Middle East, India, Africa
$5M
2%
Asia Pacific and Other
$2M
1%
Americas, excluding U.S.
$1M
0%
← FY 2023
All Quarters
Q4 2023 →